BridgeMD
New treatment option for MONITOR
Official title Promoting Early Intervention Timing and Attention to Language
ClinicalTrials.gov ID: NCT05853861
What this study is testing
- What it's testing
- The proposed study (PETAL: Promoting Early intervention Timing and Attention to Language) aims to determine the timing of intervention among infants with Increased Likelihood for Autism (ILA; at risk for autism by virtue of having an older sibling with autism) on communication and language outcomes at 24 months. Results of this study will determine when (9 vs 12 vs 15 months), and based on which measures (brain, language, or their combination) to augment parental support with a specialized parent-mediated coaching intervention for optimal outcomes on communication and language at 24 months.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 8
You may be able to join if
- This study will recruit approximately 140 infants ages 6-8 months of age who are younger siblings of children with ASD.
- Both males and females are eligible for study participation and will be recruited.
- Family income is under the very low income described under the Department of Housing and Community DevelopmentDivision of Housing Policy Agreement...
You likely can't join if
- Infants who have seizures and are not stable on anti-seizure medication
- Infant is expected to have surgery over the next year
- Infant has associated physical disorders, and/or co-morbid with other syndromes or diseases.
- All of the children will be free of additional sensory or motor impairments (e.g., Visual or hearing impairment) and othergenetic syndromes (e.g...
- In addition, infants who are premature or less than 34 weeks (gestational age \<34 weeks) will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
- Worcester, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 months to 8 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States; Worcester, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.